1. Abnormal microvasculature in chronic viral hepatitis. Issue 1 (16th February 2017) Authors: Sarcognato, S.; Farinati, F.; Cardin, R.; Russo, F.P.; Piciocchi, M.; Guzzardo, V.; Giacomelli, L.; Guido, M. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adherence to BCLC treatment algorithm and survival predictors in single node HCC in Italy. (10th February 2016) Authors: Pozzan, C.; Di Vasto, M.A.; Maddalo, G.; Vitale, A.; Trevisani, F.; Farinati, F. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AF.24 CHARACTERISTICS OF EMPIRICAL FIRST- AND SECOND-LINE TREATMENT BETWEEN 2013-2020: ITALIAN DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG). (September 2021) Authors: Gatta, L.; Fiorini, G.; Saracino, I.M.; Pavoni, M.; Romano, M.; Gravina, A.G.; Granata, L.; Pellicano, R.; Gasbarrini, A.; Di Leo, A.; Losurdo, G.; Franceschi, F.; Nardone, G.; Rocco, A.; Dore, M.P.; Farinati, F.; Ghisa, M.; Puig, I.; Nyssen, O.; Mégraud, F. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AF.79 EPIDEMIOLOGICAL TRENDS OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH METABOLIC-DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE (MAFLD) IN ITALY. (September 2021) Authors: Cucco, M.; Vitale, A.; Svegliati–Baroni, G.; Marchesini, G.; Cillo, U.; Trevisani, F.; Miele, L.; Farinati, F. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S173 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Capecitabine in advanced hepatocellular carcinoma: a multicenter experience. (February 2019) Authors: Pelizzaro, F.; Sammarco, A.; Pastorelli, D.; Giovanis, P.; Dadduzio, V.; Rizzato, M.D.; Lombardi, G.; Lonardi, S.; Peserico, G.; Imondi, A.; Sartori, A.; Maddalo, G.; Farinati, F. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Characteristics of hepatocellular carcinoma patients with long-term survival: an ITA.LI.CA report. (February 2019) Authors: Pelizzaro, F.; Vieno, A.; Peserico, G.; Imondi, A.; Sartori, A.; Penzo, B.; Trevisani, F.; Farinati, F. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Circulating microparticles and risk of portal vein thrombosis in patients with liver cirrhosis and hepatocellular carcinoma. (10th February 2016) Authors: Zanetto, A.; Ferrarese, A.; Nadal, E.; Bortoluzzi, I.; Campello, E.; Cillo, U.; Farinati, F.; Germani, G.; Russo, F.P.; Spiezia, L.; Simioni, P.; Burra, P.; Senzolo, M. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Circulating microRNA-21 and microRNA-122: prognosis prediction and correlation with HIF-1alpha in hepatocellular carcinoma patients treated with transarterial chemoembolization. (February 2020) Authors: Pelizzaro, F.; Cardin, R.; Minotto, M.; Carlotto, C.; A. Imondi, ; Sartori, A.; Penzo, B.; Sammarco, A.; Peserico, G.; Aliberti, C.; Vitale, A.; Cillo, U.; Farinati, F. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Circulating prostaglandin E2: A novel potential prognostic biomarker in patients with hepatocellular carcinoma. (March 2021) Authors: Pelizzaro, F.; Kitenge, M.P.; Cardin, R.; Penzo, B.; Ponzoni, A.; Cillo, U.; Vitale, A.; Businello, G; Munari, G.; Fassan, M.; Farinati, F. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Clinical effectiveness of enhanced surveillance in "super-high risk" cirrhotics as evaluated in the ITA.LI.CA database. Issue 1 (16th February 2017) Authors: D'Elia, M.; Peserico, G.; Pelizzaro, F.; Meneghetti, A.; Imondi, A.; Giannini, E.; Trevisani, F.; Farinati, F. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗